AMGN - Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug
2023-11-12 12:00:36 ET
More on Eli Lilly
- Eli Lilly and Company (LLY) Presents at UBS Biopharma 2023 Conference (Transcript)
- Eli Lilly: Zepbound FDA Approval Is A Sell-The-News Opportunity
- Eli Lilly's Big Win In The Obesity Space Just Got Bigger
- Eli Lilly diabetes therapy endorsed in EU for weight loss
- Eli Lilly declines a day after FDA nod for weight loss therapy
For further details see:
Eli Lilly expected to add $4.1B U.S. sales from new weight loss drug